An independent intelligence board aggregating credible research, preprints, clinical findings, biohacking experiments, and community discussions on therapeutic peptides, longevity science, and evidence-based anti-aging. Stories are scored for relevance, credibility, novelty, momentum, and practicality so the most important findings surface first.
Someone on a forum shared a personal update about using tirzepatide, a drug that’s been getting attention for weight loss. They wrote that they started the medication nine weeks ago at a low dose, stayed there for seven weeks, tried one slightly higher dose, and then increased again to 5 mg yesterday. So far they’ve lost about 4.8 kg (around 10.5 pounds) and are relieved to finally be losing weight after gaining during menopause. Tirzepatide is a prescription medication that acts like certain hormones your gut makes after you eat. Those natural hormones tell your brain to feel full and help control blood sugar. The drug copies those signals to reduce appetite and slow digestion. People often compare it to semaglutide (the active ingredient in Ozempic and Wegovy), but tirzepatide hits two different hormonal pathways at once, which may make its appetite and blood-sugar effects stronger. This post is a single-person anecdote, not a formal study. It reports modest weight loss — about 4.8 kg in nine weeks — and mentions dose changes. That outcome is within what many clinical trials have shown: some people lose substantial weight on tirzepatide, but results vary widely. Because this is one person’s experience, it doesn’t tell us how typical this pattern is, how long the weight loss will continue, or how side effects look over time. For someone curious about weight-loss drugs, this kind of update shows potential: tirzepatide can help people who’ve struggled to lose weight, including those dealing with menopause-related weight gain. It’s particularly relevant for people whose hormones or metabolism have shifted with age, making traditional diet and exercise less effective. If you’re considering this medication, it’s a reminder that progress can be gradual and dosing may be adjusted over weeks. There are important caveats. A single forum post doesn’t replace medical evidence. Tirzepatide is a prescription drug with possible side effects like nausea, diarrhea, or low blood sugar, and it may not be safe for people with certain medical histories. Dosing is individualized and should be guided by a doctor. Long-term effects and what happens after stopping the drug are still being studied. Also, insurance coverage and cost can be barriers. Bottom line: One person’s nine-week report suggests tirzepatide helped with steady, modest weight loss after menopause, but it’s just an individual story — talk to a clinician to understand realistic benefits, risks, and whether it could be right for you.
Source: r/Mounjaro